Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05259852 · ClinicalTrials.gov registry record · NA
An Intervention to Promote Smoking Cessation Among Adults With Food Insecurity
A NA study, sponsored by Case Western Reserve University.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT05259852: Completed NA study, sponsored by Case Western Reserve University.
NCT05259852 is a NA study that has completed, run by Case Western Reserve University. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05259852, a NA study, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
This is a two-arm randomized controlled study with 60 participants. The study has two aims. The first aim is to determine the feasibility and acceptability of a food assistance intervention to alleviate food insecurity during a smoking cessation attempt among low-income smokers with food insecurity. Smokers with recent food insecurity are recruited for a 12-week study that involves resources navigation for food assistance and tobacco cessation, with assessments at baseline and at 12 weeks. Participants are randomized to receive economic assistance for food in addition to resources navigation in the intervention arm, or randomized to receive resources navigation only in the control arm. The second aim is to estimate the preliminary impact of the intervention on food insecurity and tobacco cessation measures at 12 weeks.
Primary Outcome
In the past 3 months, how many times did you stop using tobacco for 24 hours or more because you were trying to quit smoking?
Interventions
- BEHAVIORAL Food Assistance and Cessation Resources Navigation Plus Economic Assistance
- BEHAVIORAL Food Assistance and Cessation Resources Navigation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2022-02-10 |
| Est. Completion | 2023-04-23 |
| Phase | NA |
What the finished NCT05259852 record still lists
NCT05259852 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Food Assistance and Cessation Resources Navigation Plus Economic Assistance is the first listed.
NCT05259852 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05259852 about?
NCT05259852 is a clinical study titled "An Intervention to Promote Smoking Cessation Among Adults With Food Insecurity". This is a two-arm randomized controlled study with 60 participants. The study has two aims. The first aim is to determine the feasibility and acceptability of a food assistance intervention to alleviate food insecurity during a smoking cessation attempt among low-income smokers with food insecurity....
What is the current status of trial NCT05259852?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2022-02-10. Estimated completion is 2023-04-23.
What interventions are being tested in trial NCT05259852?
The interventions under investigation include: Food Assistance and Cessation Resources Navigation Plus Economic Assistance (BEHAVIORAL), Food Assistance and Cessation Resources Navigation (BEHAVIORAL).
Who is sponsoring clinical trial NCT05259852?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05259852's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI